The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I love the idea here but the current financial climate for small pre revenue biotech companies is extremely tough.
ANIC needs considerably more cash to continue investing in follow on funding rounds, even to maintain current equity positions in portfolio CO’s, and exploring new investments.
With the share price miserably low a large raise risks huge dilution to holders, and would negatively skew/inflate the mcap. Instead, the company appears to be sitting on its hands hoping the tide turns, losing out on vital %s as these early portfolio companies make progress.
Catch22! Waiting until they improve their balance sheet before taking a sizeable position AIMO
Absolutely staggering, FTSE 100 calibre salaries being paid out for employees. Really puts it into perspective when the chart confirms the company is over 92% down from 2021 highs, with obscene salaries paid for by annual shareholder dilution as the company generates very little revenue.
Flabbergasted - no wonder the SP is tanking, and that’s without the drill results!
I anticipate Mystic Mac (I googled the name as you suggested and it came up with a fraud case for a pump and dump LOL) will have disappeared in a week after his rampathon and a lot of confused naive punters will be left holding a rather expensive baby.
Bookmark this post!
My prediction - the current SFS horizon will be a duster with mainly frac fluid/water returned and perhaps minor amounts/traces of oil.
Attention will turn to the second flow test of SMD-B which will overrun and have to be postponed, citing it looks ‘encouraging’ and they will return next year. Lipstick comments will include solid pressure build up and trace oil proving a working hydrocarbon system is present etc etc
A few more cash raises to keep the gravy train going and go again next year.
7k BOPD is exceptional! AETs management really know how to improve these assets both operationally and environmentally as demonstrated over the last year. Not to mention the reserves replacement which has been achieved to date - so much running room in these assets.
Looking forward to final closure of Azule which is edging closer with the latest approvals, and clearly more deals in the pipeline! A steal at £87m mcap - Strong BUY
Cash is running low, negotiations will be from a position of weakness.
Some holders anticipating a miraculous buyout or licensing deal. This the AIM and the likelihood is a discounted placing imo. Target placing price 75p to give another 12 months runway I suspect.
UK O&G is finished. Labour are already talking of retrospective ‘proper’ windfall tax which will be backdated. SQZ has a long to way drop from here unfortunately - should’ve merged with Kistos when they had the chance but instead it seems MF has egg on his chin and ran away into the sunset.
Officially confirmed Afentra is now a money making machine. Lots to look forward to and a snip at £70m mcap. Congratulations to all holders it has been a long wait!